Axogen Director Amy McBride-Wendell Receives 14,150 Shares from Restricted Stock Unit Vesting

This Form 4 filing reports that Amy McBride-Wendell, a director of Axogen, Inc., received 14,150 shares of common stock on June 19, 2026, through the vesting of restricted stock units. The transaction represents an annual equity grant for her service on the Axogen Board of Directors, valued at $150,000 as of the grant date. The restricted stock units vested on the one-year anniversary of the grant date. Following this transaction, McBride-Wendell now holds 107,976 shares of Axogen common stock directly. The filing includes standard director compensation disclosure for equity awards and demonstrates routine board compensation practices.